Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: J Hosp Med. 2022 Nov 22;18(2):120–129. doi: 10.1002/jhm.13009

TABLE 3.

Hospital-level analysis of pharmacologic restraint use between hospitals

Effect Level Number of hospitals Median [IQR] adjusteda rate p Value
Average daily census <125 3 229.5 [111.5, 243.5] .313
126–200 14 168.5 [123, 204.4]
201–300 25 189.5 [150.1, 225.1]
301+ 7 134.2 [95.7, 214.4]
Hospital region Midwest 14 146.3 [119.6, 196] .106
Northeast 6 110.3 [103.6, 184.7]
South 17 179.9 [151.7, 214.4]
West 12 215 [137.6, 228.1]
Mental health encountersb (as a total of inpatient/observation encounters) Q1 12 185.6 [107.6, 223.7] .099
Q2 12 167 [138.2, 255.3]
Q3 13 190.8 [151.7, 243.5]
Q4 12 141.5 [91.1, 177.3]
Presence of inpatient psychiatric unit No 21 182.9 [136.4, 226.6] .460
Yes 28 159.5 [119.6, 206.8]

Abbreviations: CCC, complex chronic conditions; DSM-V, Diagnostic and Statistical Manual of Mental Disorders, 5th Edition; H-RISK, Hospitalization Resource Intensity Scores for K; ICU, intensive care unit.

a

Covarities adjusted for include DSM-V category, CCC, ICU stay, length of stay, H-RISK, age, sex, payor, and hospital disposition.

b

Quartile 1 is the bottom quartile of the number of mental health encounters and quartile 4 is the top quartile.